2023Highlights
2023 was a productive year for OSE with 9 new spinouts launched, 32 additional companies financed and significant momentum across our portfolio of Deep Tech, Life Sciences and Health Tech.
Our team of experienced investors and company builders continued to grow as we welcomed Ed Bussey as our new CEO and introduced the position of Chief Investment Officer, appointing Jack Edmondson.
We continue to work with our partners and co-investors to build a vibrant spinout ecosystem in Oxford.
Read on for a selection of 2023 highlights...
What people are saying
Top investor of women-powered businesses
Top Investor in UK university spinouts
Top 10 most active investors in European biotechs
FOUND
Driving the development of
Next-generation hardware supporting the AI revolution
Novel therapies for cancer, rare, and retinal diseases
New approaches to clean energy
Digital tools for better drugs and health outcomes
FUND
Raised across the portfolio: £148m from OSE, and £220m+ from UK and international co-investors. New investments in two later-stage companies.
BUILD
Awarded FDA Breakthrough Device Designation for the company’s heart failure AI platform.
